Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Detection of Genetic Markers of Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Pittsburgh
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00280202
First received: January 18, 2006
Last updated: December 1, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2050
  Estimated Primary Completion Date: December 2050 (Final data collection date for primary outcome measure)